异形多发局部性脂肪缩,模仿肌缩侧面硬化症
Shuhei Mashimo1, Ayano Matsuoka2, Keiji Tanese1
1Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.
Cureus
|January 1, 2025
概括
异常局部脂肪缩,一种罕见的脂肪损失状况,可以呈现神经症状和炎症. 这一案例突出了局部脂肪缩的不寻常的临床和组织学发现.
科学领域:
- 皮肤病学 皮肤病学
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 局部化脂肪缩包括皮下脂肪的损失.
- 异常形式缺乏已知的触发因素,并具有未知的病原体.
- 罕见的病例可能呈现异常的临床或组织学特征.
研究的目的:
- 报告一种独特的异常局部化脂肪缩病例.
- 描述临床表现和组织学发现.
- 为了解这种罕见疾病的发病因子做出贡献.
主要方法:
- 一个53岁的日本妇女的案例介绍.
- 临床检查,包括对神经症状的评估.
- 组织学检查受影响的组织.
主要成果:
- 患者出现了多个局部性脂肪缩的区域.
- 临床发现包括上部运动神经元的迹象.
- 组织学分析显示脂肪细胞的破坏与突出的血细胞透.
结论:
- 这一案例表明局部脂肪缩与神经症状和特定炎症透物的异常关联.
- 这些发现表明局部脂肪缩和炎症过程之间存在潜在的联系.
- 需要进一步的研究来阐明异常局部化脂肪缩的发病原因.
更多相关视频
相关概念视频
Cross-bridge Cycle
115.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
115.7K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Myasthenia Gravis: Overview and Treatment
932
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
932
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K


